Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of aspirin, enoxaparin, and rivaroxaban for prevention of postoperative coagulopathy after total knee arthroplasty
IRCT20181128041784N1Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Dec 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of aspirin, enoxaparin and rivaroxaban in venous thromboembolism (VTE) (4 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoints: Deep vein thrombosis, Pulmonary thromboembolism and 1 more. Started Dec 2018; status: completed.
02
Drugs
aspirinenoxaparinrivaroxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on IRCT20181128041784N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181128041784N1.